those of the racemate.3 The analogous preparation of N7-
and C-substituted derivatives of exo-1, which were particu-
larly active as R7 nicotinic acetylcholine receptors, was
reported in a patent.4 A longer sequence of steps, also
including a cycloaddition step of N-Boc pyrrole and a
resolution step, was necessary to prepare the dihydroxy
derivatives exo- and endo-4, which were active as glycosidase
inhibitors.5
These previously described routes led to racemic com-
pounds which were resolved to the enantiomers, considerably
reducing the yield of the desired optically pure compounds.
Hence, we envisioned an alternative asymmetric synthesis
of (+)- and (-)-endo-1 starting from enantiomerically pure
trans-1,2-diaminocyclohex-4-ene derivatives which are easily
prepared in two steps from the glyoxal diimines derived from
(R)- or (S)-1-phenylethanamine, e.g., 5 (Scheme 1).6,7 Our
Our first attempt was to perform a hydroboration reaction
on the diaminocyclohexene derivative 5 because the hy-
droboration of N,N′-bis[1(S)-phenylethyl]-4(R),5(R)-diami-
noocta-1,7-diene, the precursor of 5,6 was previously de-
scribed using 9-BBN.8 In our hands, using freshly prepared
9-BBN (2.5 equiv), a partial conversion of the alkene
function to give the alcohol 8 (ca. 20%, dr 3:1) was observed
by 1H NMR analysis of the crude product obtained after the
usual treatment with H2O2-NaOH (Scheme 2). In further
Scheme 2. Preparation of
N,N′-Disubstituted-3,4-diaminocyclohexanols 8a,b
Scheme 1. Planned Route to endo-1
experiments carried out increasing progressively the amounts
of 9-BBN up to 10 equiv, the conversion of 5 to the alcohol
8 (dr 75:25) progressively raised to 98%. The diastereoiso-
mers 8a and 8b were obtained pure by column chromatog-
raphy (SiO2) in 62% and 18% yield, respectively. Fractions
containing both diastereoisomers were also eluted (7%). The
equatorial and axial dispositions of the OH substituent in
the cyclohexane ring in 8a and 8b, respectively, were
assessed by NMR studies and later confirmed by the
outcomes of the subsequent ring closure step.
Other commercially available reagents, including BH3·Et3N,
BH3·PPh3, catecholborane, and BHBr2·SMe2, proved ineffective.
However, the use of BH3·SMe2 (3 equiv) allowed us to obtain
a moderate conversion to the diaminocyclohexanols 8a and 8b.
Increased amounts of the borane reagent, more forcing condi-
tions for the oxidative step, and increased reaction times did
not raise the yield of 8 over 50% (dr 65:35, determined by 1H
NMR analysis). The starting material was totally consumed,
but other compounds were present in the crude mixture and
were collected together in the first fractions eluted by column
chromatography. They are presumably organoboron species, but
their structure could not be determined.
Aiming to avoid formation of such boron-nitrogen species
and, if possible, to increase the diastereoselectivity, we
thought to protect the secondary amines of 5 by forming the
aminal with formaldehyde, as this protection can be readily
accomplished as well as removed (Scheme 3). Actually, the
aminal 9 was quantitatively formed by reaction of 5 with an
excess of paraformaldehyde in dichloromethane. Then, the
hydroboration occurred smoothly using 2.5 equiv of
BH3·SMe2 followed by oxidation. Column chromatography
(SiO2) afforded the inseparable mixture of 10a,b in 70% yield
(10a/10b ) 60:40). Also eluted were the cyclohexane
idea was to exploit the reactivity of the cyclohexene function
to introduce a substituent with leaving group ability and the
proper stereochemistry, as in structure 6. This compound
would undergo easy ring closure by nucleophilic displace-
ment by the trans-disposed amino group to give the bicyclic
compound 7. Then, routine hydrogenolysis would afford the
desired compound endo-1.
(3) (a) Hof, F.; Schu¨tz, A.; Fa¨h, C.; Meyer, S.; Bur, D.; Liu, J.; Goldberg,
D. E.; Diederich, F. Angew. Chem., Int. Ed. 2006, 45, 2138–2141. (b)
Zu¨rcher, M.; Gottschalk, T.; Meyer, S.; Bur, D.; Diederich, F. ChemMed-
Chem. 2008, 3, 237–240.
(4) Wishka, D. G.; Walker, D. P.; Corbett, J. W.; Reitz, S. C.;
Rauckhorst, M. R.; Groppi, V. E., Jr. Substituted 7-aza[2.2.1]bicycloheptanes
for the treatment of deseases, EP 1 425 286 B1, 2004.
(5) Moreno-Vargas, A. J.; Schu¨tz, C.; Scopelliti, R.; Vogel, P. J. Org.
Chem. 2003, 68, 5632–5640.
(6) Alvaro, G.; Grilli, S.; Martelli, G.; Savoia, D. Eur. J. Org. Chem.
1999, 1523–1526.
(7) Racemic trans- and cis-1,2-diaminocyclohex-4-ene were used to
prepare all the diastereomers of 4,5-diaminocyclohexan-1,2-diols: Witiak,
D. T.; Rotella, D. P.; Filippi, J. A.; Gallucci, J. J. Med. Chem. 1987, 30,
1327–1336. Witiak, D. T.; Wei, Y. J. Org. Chem. 1991, 56, 5408–5417
N,N′-(Boc)2-(S,S)-1,2-diaminocyclohex-4-ene was prepared by a long
sequence of steps including the catalytic asymmetric ring opening of the
N-(3,5-dinitro)benzoyl derivative of cyclohexa-1,4-diene monoaziridine:
Fukuta, Y.; Mita, T.; Fukuda, N.; Kanai, M.; Shibasaki, M. J. Am. Chem.
Soc. 2006, 128, 6312–6313.
(8) Alexakis, A.; Tomassini, A.; Chouillet, C.; Roland, S.; Mangeney,
P.; Bernardinelli, G. Angew. Chem., Int. Ed. 2000, 39, 4093–4095.
Org. Lett., Vol. 12, No. 21, 2010
4965